Scottsdale, AZ, United States of America

Hongwei Yin

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Phoenix, AZ (US) (2017)
  • Scottsdale, AZ (US) (2016 - 2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovative Contributions of Innovator Hongwei Yin in Cancer Therapeutics

Introduction: Hongwei Yin is an accomplished inventor based in Scottsdale, AZ, known for his groundbreaking work in cancer research and therapeutics. With a remarkable portfolio of three patents, Yin has been instrumental in advancing methods and treatments aimed at improving patient outcomes for various cancers.

Latest Patents: Hongwei Yin's recent innovations include several patents that focus on predictive methods and treatments related to BTK inhibitors. His first patent outlines methods and kits designed to predict therapeutic outcomes for subjects with pancreatic cancer, specifically assessing the expression of DPC4 (SMAD4) to identify individuals likely to respond positively or negatively to treatment with BTK inhibitors. Furthermore, he has developed methods for treating patients based on these identifications, targeting cancers with an inactivated DPC4 gene or protein. His second patent pertains to the screening of new therapeutic agents using these identified targets, including pharmaceutical compositions containing BTK inhibitors such as PCI-32765, aimed at enhancing cancer treatment strategies. Additionally, Yin's patent focuses on screening compounds that inhibit the interaction of FN14-tweak, providing new avenues for treating cell proliferative disorders through the use of heterocyclic compounds.

Career Highlights: Hongwei Yin's career is marked by his significant contributions to cancer therapeutics. He is currently associated with the Translational Genomics Research Institute, where he collaborates with leaders in the field to push the boundaries of genomic medicine. His work emphasizes developing therapeutic strategies that directly address the molecular complexities of cancer, making him a valuable asset in the ongoing fight against the disease.

Collaborations: Throughout his career, Yin has worked alongside notable colleagues including Haiyong Han and Daniel D Von Hoff. These collaborations have fostered a rich environment for innovative ideas and approaches, contributing to the advancement of cancer research and treatment protocols.

Conclusion: Hongwei Yin stands out as a pioneering inventor whose work in predicting therapeutic responses and developing innovative treatments has the potential to significantly improve the lives of cancer patients. His patents reflect a deep commitment to scientific research, which continues to inspire advancements in oncology and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…